Skip to content
Credit reportVerdict and grounds
Made on 18-11-2026 at 19:08
Reference CK-0865158341-20261118

DOLCEPHARMA

ActivePrivate limited company0865.158.341Brusselsesteenweg 713, 9050 Ghent
Agents in the wholesale of furniture, household goods and hardware (NACE 46150) · founded in 2004 · 2 employees on 31-12-2025 · one director · accounts in the micro format

Sources: the KBO register on 18-11-2026; the National Bank, 2025 annual accounts filed on 29-06-2026; the Belgian Official Gazette, latest deed of 22-10-2019.

Credit verdict
Checked score 2025
The score, from 0 to 100, reflects the bankruptcy probability and the standing among sector peers.
Bankruptcy probability within 12 months
The median of 26,886 micro companies in the wholesale trade sector (NACE 46) is 0.4%.
Gross margin
€166,450
▼ 4.1% against 2024
Net result
€17,393
▼ 56.6% against 2024
Equity
€197,065
▲ 9.7% against 2024
Cash
€70,844
▼ 40.5% against 2024

Grounds

the facts the verdict rests on, each with its source
  1. In 2025, DOLCEPHARMA closed with a net profit of €17,393.Annual accounts 2025 page 2
  2. Equity stands at €197,065, or 64.6% of the balance sheet total of €304,973. That is more than 76% of the 15,503 companies in the wholesale trade sector (NACE 46).Annual accounts 2025 page 2
  3. The 2025 accounts reached the National Bank 32 days before the end of the term.National Bank, filing of 29-06-2026 page 5
  4. (0831.387.295) holds 99.46% of the shares. Its equity stood at €541,471 on 30-06-2025.Annual accounts 30-06-2025 of page 3

Representation

The signing rule is in the deed of 22-10-2019.

Articles of association, Belgian Official Gazette of 22-10-2019, deed 19340119

Ownership

(0831.387.295) holds 99.46% of the shares. Its equity stood at €541,471 on 30-06-2025.

Annual accounts 30-06-2025 of

DOLCEPHARMA · 0865.158.341 · credit report of 18-11-2026Page 1 of 6
DOLCEPHARMA0865.158.341 · report of 18-11-2026

Financial situation

Annual accounts 2021 to 2025, as filed with the National Bank

Gross margin and net resultin euro

2021151,9792022135,7572023150,0172024173,6202025166,450202133,645202236,955202347,470202440,080202517,393
gross marginnet result

Equity and debtsin euro

20212022202320242025197,065107,909
equitydebts

Cashin euro

202162,1372022129,262202395,4522024119,050202570,844
on the balance sheet date
Financial year20212022202320242025Trend
Results
Gross margin€151,979€135,757€150,017€173,620€166,450
Operating result€36,810€34,029€27,139€15,866-€14,769
Net result€33,645€36,955€47,470€40,080€17,393
Balance sheet at the closing date
Equity€175,166€152,122€159,592€179,672€197,065
Debts€71,657€169,543€141,116€163,356€107,909
Debts due within one year€64,008€159,538€126,549€159,947€104,569
Cash€62,137€129,262€95,452€119,050€70,844
Balance sheet total€246,824€321,664€300,708€343,028€304,973
Operations
Employees in full-time equivalents1.91.51.81.81.8
Ratios
Solvency71.0%47.3%53.1%52.4%64.6%
Liquidity3.751.932.302.092.83

Source: Annual accounts 2025, micro format, filed on 29-06-2026 (2026-00224826); Annual accounts 2024, micro format, filed on 26-06-2025 (2025-00183688); Annual accounts 2021 to 2023, filed from 25-08-2022 to 09-08-2024 (2022-20382532, 2023-00458408, 2024-00337708).

Debts fell by €55,448 in 2025.

The 2025 annual accounts state no amount of overdue tax or social security (RSZ) debts.

DOLCEPHARMA states no turnover; the micro format does not require it. The gross margin, what is left after purchases, fell from €173,620 to €166,450.

DOLCEPHARMA · 0865.158.341 · credit report of 18-11-2026Page 2 of 6
DOLCEPHARMA0865.158.341 · report of 18-11-2026

Board, signature and ownership

Position on 18-11-2026 according to the deeds in the Belgian Official Gazette and the annual accounts

Who represents the company

The signing rule is in the deed of 22-10-2019.

Articles of association, Belgian Official Gazette of 22-10-2019, deed 19340119

Board

one director in office
Niet statutaire zaakvoerder van de bvbaappointed by deed of 22-10-2019
deed of 22-10-2019

Ownership and group

Shareholders

(0831.387.295) holds 99.46% of the shares. Its equity stood at €541,471 on 30-06-2025.

Annual accounts 30-06-2025 of

Board changes

changes role from manager to niet statutaire zaakvoerder van de bvba. resigns as manager. Director discharge: . Legal-form conversion: from private limited company (pre-2019) to private limited company. General meeting of 01-04-2019.

Gazette, deed 19340119

New manager. appointed, resigned. General meeting of 01-04-2019.

Gazette, deed 19052352
DOLCEPHARMA · 0865.158.341 · credit report of 18-11-2026Page 3 of 6
DOLCEPHARMA0865.158.341 · report of 18-11-2026

Group

has 1 direct subsidiary (accounts to 30-06-2025).

Country Company Equity Result
Belgium 1
BE Dolcepharmathis company99.46% €197,065 result €17,393

Source: List of holdings in the accounts to 30-06-2025 of . Every holding stands with its own latest accounts.

DOLCEPHARMA · 0865.158.341 · credit report of 18-11-2026Page 4 of 6
DOLCEPHARMA0865.158.341 · report of 18-11-2026

Events and comparison

The latest events, newest first

Annual accounts 2025 filed, 32 days before the deadline.

NBB filing

Registered in the Peppol Directory. Reachable for e-invoices through 0208:0865158341.

Annual accounts 2024 filed, 35 days before the deadline.

NBB filing

Annual accounts 2023 filed, 9 days late.

NBB filing

Highest result from 2006 to 2025. The net result of €47,470 is the highest of those years.

Financial

Annual accounts 2022 filed, 57 days late.

NBB filing

Annual accounts 2021 filed, 25 days late.

NBB filing

Equity above €150,000. After 12 profitable years in a row, equity reaches €175,166.

Financial

Annual accounts 2020 filed, 39 days late.

NBB filing

Annual accounts 2019 filed, 32 days before the deadline.

NBB filing

changes role from manager to niet statutaire zaakvoerder van de bvba. resigns as manager. Director discharge: . Legal-form conversion: from private limited company (pre-2019) to private limited company. General meeting of 01-04-2019.

Gazette, deed 19340119

Annual accounts 2018 filed, 28 days late.

NBB filing

New manager. appointed, resigned. General meeting of 01-04-2019.

Gazette, deed 19052352

Annual accounts 2017 filed, 31 days late.

NBB filing

Comparable companies, two years later

In July 2024, 31,389 companies had the same profile as DOLCEPHARMA has now: micro, 20 years or older, solvency 30% or more and a profit of 5% of the balance sheet or more. Two years later 93.4% were still trading, 6.1% had stopped another way and 0.5% had gone bankrupt.

still trading 93.4% stopped another way 6.1% bankrupt 0.5%

In 2025, DOLCEPHARMA had a higher net result than 67% of the 15,467 companies in the wholesale trade sector (NACE 46).

Other findings

Peppol

Reachable for e-invoices since 22-12-2025, under 0208:0865158341.

Sanctions lists

Staff

2 employees on 31-12-2025, 1.8 full-time equivalents on average over the year.

DOLCEPHARMA · 0865.158.341 · credit report of 18-11-2026Page 5 of 6
DOLCEPHARMA0865.158.341 · report of 18-11-2026

Sources and method

Where each fact in this report comes from

SourceWhatDateReference
KBO registerRegistration, legal situation, activity, establishment units18-11-2026KBO 0865.158.341
National Bank of BelgiumAnnual accounts 2025, micro format29-06-20262026-00224826
National Bank of BelgiumAnnual accounts 2024, micro format26-06-20252025-00183688
National Bank of BelgiumAnnual accounts 2021 to 202325-08-2022 to 09-08-20242022-20382532, 2023-00458408, 2024-00337708
Belgian Official GazetteArticles of association with the signing rule22-10-2019deed 19340119
Belgian Official GazetteBoard16-04-2019deed 19052352
Peppol DirectoryRegistration for e-invoices22-12-20250208:0865158341
Sanctions lists EU, UN, US (OFAC) and UKComparison of the name16-11-2026no match
CheckedChecked score, bankruptcy probability, credit, comparable companies17-11-2026bankruptcy model of 2 October 2026

Method

Checked score. A number from 0 to 100. The bankruptcy probability sets the class, from Critical to Excellent; within the class, the comparison with sector peers on solvency, liquidity, profitability and growth counts for half.

Bankruptcy probability. The probability that the company goes bankrupt within 12 months, estimated from the KBO register, the annual accounts and the Gazette with the bankruptcy model of 2 October 2026, computed on 17-11-2026.

Credit. The credit is a tenth of equity, weighted by the score, and never more than a tenth of turnover. With negative equity there is no credit.

Payment terms. Supplier credit is the debt to suppliers divided by the year's purchases, times 365. Customer credit is the same for what customers still owe, against turnover.

Comparable companies. Companies of the same size, age, solvency and profitability at an earlier date, followed two years later in the KBO register and the Gazette.

The scores and ratios are Checked's own calculations, not a credit decision.

DOLCEPHARMA · 0865.158.341 · credit report of 18-11-2026Page 6 of 6